Food for Thought...Howard H. Pien..Melanoma..Jim Breitfeller

Howard H. Pien, M.B.A.
Mr. Howard H. Pien , 51
Chairman, Chief Exec. Officer and Pres

Annual Salary $ 1.46M

CEO of Medarex



They make the CTLA-4 antibodies

"Mr. Pien is the Chairman of our Board and our President and Chief Executive Officer. Prior to joining us in June 2007, Mr. Pien was the Chairman and Chief Executive Officer and a Director of Chiron Corporation, a biopharmaceutical company involved in three healthcare markets: blood testing, vaccines, and biopharmaceuticals, from April 2003 until Chiron's merger with Novartis in April 2006. From April 2006 to June 2007, Mr. Pien performed consulting services. He joined Chiron from GlaxoSmithKline, where he held roles in commercial operations and general management, including positions as the head of the international business. Mr. Pien previously held key positions in SmithKline Beecham's pharmaceuticals business in the United States, the United Kingdom, and North Asia, culminating in his tenure as President, Pharmaceuticals-North America and head of the worldwide pharmaceutical and vaccines businesses. Prior to joining SmithKline Beecham, he worked for six years for Abbott Laboratories and five years for Merck & Co., in positions of sales, market research, licensing and product management. Mr. Pien is a Massachusetts Institute of Technology graduate and received an M.B.A. from Carnegie-Mellon University. Mr. Pien currently serves as a director of ViroPharma Incorporated and Vanda Pharmaceuticals, Inc., each a publicly traded biotechnology company."

Source:Yahoo Finance

2004 shorage and contamination of the FLU Vaccine

http://archives.energycommerce.house.gov/press/108ltr161.pdf


Contamination of Vaccines


Do you see a pattern emerging?



Take Care,

Jimmy B